View Document Preview and Link Document Date: 2012-05-30 15:35:22 Open Document File Size: 424,29 KB Share Result on Facebook
Company IMS Health Inc. / MySQL / / Country United States / / / Facility National Library / / IndustryTerm pharmaceutical industry / retail / biological product / prevention of stroke / food / straightforward solution / / MedicalCondition strokes / e.g. depression / inflammatory bowel disease / liver failure / occasion liver failure / acute and chronic pancreatitis / rheumatoid arthritis / nausea / Toxic Epidermal Necrolysis / Stevens-Johnson syndrome / blood clots / birth defect / serious injury / injury / pulmonary embolism / MS / percent* Severe liver injury / birth defects / autoimmune disorders / stroke / diabetes / severe acne / Rhabdomyolysis / fatal injury / psychiatric disorders / pancreatitis / irreversible movement disorders / epilepsy / atrial fibrillation / unwanted blood clots / renal failure / depression / cases Severe Liver Injury / serious injuries / alleged patient injuries / acute renal failure / injuries / / MedicalTreatment drug therapies / drug therapy / / Organization Wake Forest University School of Medicine Media Inquiries Renee Brehio ISMP Public Affairs / Institute for Safe Medication Practices / U.S. Food and Drug Administration / FDA / / Person Drug Safety / Thomas J. Moore / Michael R. Cohen / Curt D. Furberg / / / Position President / Professor of Public Health Sciences / QuarterWatch Project Director / Scientist / Executive / / Product Safe Medication / CARBOPLATIN / ACETAMINOPHEN / BYETTA / SIMVASTATIN / REGLAN / ZESTRIL / CRESTOR / REMICADE / ACCUTANE / YAZ / LEVOFLOXACIN / CHANTIX / ESTRADIOL / COUMADIN / LISINOPRIL / LAMOTRIGINE / SEROQUEL / LEVAQUIN / AVANDIA / ROSIGLITAZONE / YASMIN / ZOCOR / METOCLOPRAMIDE / LAMICTAL / / URL http / SocialTag 
QuarterWatch Monitoring FDA MedWatch Reports Anticoagulants the Leading Reported Drug Risk in 2011 May 31, 2012 New Data from 2011 Quarters 3 - 4